Nitrosative injury and antioxidant therapy in the management of diabetic neuropathy.

Oxidative stress and diabetic retinopathy. Exp Diabetes Res (2007) 2.20

The world pandemic of vitamin D deficiency could possibly be explained by cellular inflammatory response activity induced by the renin-angiotensin system. Am J Physiol Cell Physiol (2013) 1.56

Na+/H+ exchanger 1 inhibition reverses manifestation of peripheral diabetic neuropathy in type 1 diabetic rats. Am J Physiol Endocrinol Metab (2013) 0.83

Spatial, temporal, and quantitative manipulation of intracellular hydrogen peroxide in cultured cells. Methods Enzymol (2014) 0.75

Advances in diabetes for the millennium: vitamins and oxidant stress in diabetes and its complications. MedGenMed (2004) 0.75

Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev (2004) 2.83

Microvascular complications of impaired glucose tolerance. Diabetes (2003) 1.88

Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trial. Muscle Nerve (2010) 1.82

Physiological characterization of neuropathy in Fabry's disease. Muscle Nerve (2002) 1.70

Oxidative stress and programmed cell death in diabetic neuropathy. Ann N Y Acad Sci (2002) 1.67

Autonomic dysfunction in obstructive sleep apnea is associated with impaired glucose regulation. Sleep Med (2007) 1.67

Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity. Diabetes Metab Res Rev (2011) 1.62

SOD2 protects neurons from injury in cell culture and animal models of diabetic neuropathy. Exp Neurol (2007) 1.38

The Utah Early Neuropathy Scale: a sensitive clinical scale for early sensory predominant neuropathy. J Peripher Nerv Syst (2008) 1.36

Localization of the transcriptional coactivator PGC-1alpha to GABAergic neurons during maturation of the rat brain. J Comp Neurol (2007) 1.25

Uncoupling proteins prevent glucose-induced neuronal oxidative stress and programmed cell death. Diabetes (2004) 1.19

Reliability of quantitative sudomotor axon reflex testing and quantitative sensory testing in neuropathy of impaired glucose regulation. Muscle Nerve (2009) 1.05

A trial of proficiency of nerve conduction: greater standardization still needed. Muscle Nerve (2013) 1.04

"Unequivocally Abnormal" vs "Usual" Signs and Symptoms for Proficient Diagnosis of Diabetic Polyneuropathy: Cl vs N Phys Trial. Arch Neurol (2012) 1.04

Recent advances in drug-induced neuropathies. Curr Opin Neurol (2002) 1.01

Advances in understanding drug-induced neuropathies. Drug Saf (2006) 0.99

Multicenter trial of the proficiency of smart quantitative sensation tests. Muscle Nerve (2014) 0.94

Metabotropic glutamate receptor 3 protects neurons from glucose-induced oxidative injury by increasing intracellular glutathione concentration. J Neurochem (2007) 0.91

Overexpression of SIRT1 protein in neurons protects against experimental autoimmune encephalomyelitis through activation of multiple SIRT1 targets. J Immunol (2013) 0.90

Evidence-based guideline: treatment of painful diabetic neuropathy--report of the American Association of Neuromuscular and Electrodiagnostic Medicine, the American Academy of Neurology, and the American Academy of Physical Medicine & Rehabilitation. Muscle Nerve (2011) 0.89

Regulation of PGC-1alpha and PGC-1alpha-responsive genes with forskolin-induced Schwann cell differentiation. Neurosci Lett (2008) 0.89

Evidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. PM R (2011) 0.87

Transforming growth factor-beta induces cellular injury in experimental diabetic neuropathy. Exp Neurol (2008) 0.87

Treatment of diabetic sensory polyneuropathy. Curr Treat Options Neurol (2011) 0.86

Protection against glucose-induced neuronal death by NAAG and GCP II inhibition is regulated by mGluR3. J Neurochem (2004) 0.86

Identification of novel targets for PGC-1alpha and histone deacetylase inhibitors in neuroblastoma cells. Biochem Biophys Res Commun (2008) 0.86

Proficiency of nerve conduction using standard methods and reference values (Cl. NPhys Trial 4). Muscle Nerve (2014) 0.84

A novel PGC-1α isoform in brain localizes to mitochondria and associates with PINK1 and VDAC. Biochem Biophys Res Commun (2013) 0.83

Imaging findings associated with cognitive performance in primary lateral sclerosis and amyotrophic lateral sclerosis. Dement Geriatr Cogn Dis Extra (2013) 0.83

Metabotropic glutamate receptors (mGluRs) and diabetic neuropathy. Curr Drug Targets (2008) 0.81

Diabetic neuropathies. Continuum (Minneap Minn) (2014) 0.80

Metabotropic glutamate receptor regulation of neuronal cell death. Exp Neurol (2003) 0.79

Maintaining efficacy in the treatment of diabetic peripheral neuropathic pain: role of duloxetine. Diabetes Metab Syndr Obes (2010) 0.75

Immunotherapy for idiopathic lumbosacral plexopathy. Cochrane Database Syst Rev (2013) 0.75

Richard F. Mayer, MD (1929-2016). Neurology (2017) 0.75